Filing Details

Accession Number:
0001181431-10-021713
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-15 13:00:00
Reporting Period:
2010-04-13
Filing Date:
2010-04-15
Accepted Time:
2010-04-15 16:03:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1135906 Combinatorx Inc CRXX Pharmaceutical Preparations (2834) 043514457
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1432004 T Hartley Richardson C/O Combinatorx, Incorporated
245 First Street, 3Rd Floor
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-13 161,200 $1.24 199,357 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,426,835 Indirect By James Richardson & Sons, Limited
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.20 to $1.30, inclusive. The reporting person undertakes to provide to CombinatoRx, Incorporated, any security holder of CombinatoRx, Incorporated, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. Represents securities held by James Richardson & Sons, Limited. The reporting person may be deemed to have an indirect pecuniary interest in securities held by James Richardson & Sons, Limited. The reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.